ERBB2 and breast carcinoma: However, the exact rate of BRCA1/2 PV may be higher in patients with ER+/HER2- breast cancer, particularly because BRCA2 PV carriers frequently do not fully fill in personal or family testing criteria in approximately 50% of cases [106].